epirubicin has been researched along with Female Genital Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, T; Gao, Y; Ozaki, Y; Shimizu, M; Yamada, S | 1 |
| Sevin, BU; Untch, M | 1 |
| Maluf, FC; Spriggs, D | 1 |
| Jarosch, E; Lechner, W; Philadelphy, H; Sachsenmaier, M; Söldner, E | 1 |
| Daxenbichler, G; Hetzel, H; Lechner, W; Marth, C; Reider, W | 1 |
1 review(s) available for epirubicin and Female Genital Neoplasms
| Article | Year |
|---|---|
Anthracyclines in the treatment of gynecologic malignancies.
Topics: Anthracyclines; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Genital Neoplasms, Female; Humans; Mitoxantrone | 2002 |
4 other study(ies) available for epirubicin and Female Genital Neoplasms
| Article | Year |
|---|---|
The effects of chemotherapy including cisplatin on vitamin D metabolism.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Adult; Antineoplastic Combined Chemotherapy Protocols; Calcifediol; Calcitriol; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Genital Neoplasms, Female; Humans; Kidney Diseases; Kidney Tubules, Proximal; Middle Aged; Mitochondria; Mitomycin; Parathyroid Hormone; Vitamin D | 1993 |
Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Epirubicin; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Tumor Cells, Cultured | 1994 |
[Magnesium deficiency caused by epirubicin/cisplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Furosemide; Genital Neoplasms, Female; Humans; Magnesium; Magnesium Deficiency; Middle Aged | 1989 |
Estimation of cardiotoxicity of epirubicin-cisplatin by determination of myoglobin.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Epirubicin; Female; Genital Neoplasms, Female; Heart Diseases; Humans; Middle Aged; Myoglobin | 1986 |